In the Media

MIT researchers have developed a “simple way to administer long-acting drug delivery systems without the need for invasive procedures – an appealing prospect for parts of the world with poor medical infrastructure,” reports Nicola Davis for The Guardian. “It’s suitable for any poorly soluble hydrophobic drug, especially where long-acting delivery is needed,” says Prof. Giovanni Traverso, “This includes treatments for HIV, TB, schizophrenia, chronic pain, or metabolic disease​.”